|
PainReform Ltd. (PRFX) DCF Valoración
IL | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
PainReform Ltd. (PRFX) Bundle
¡Descubra el verdadero valor de PainReform Ltd. (PRFX) con nuestra calculadora DCF avanzada! Ajuste los supuestos esenciales, explore diversos escenarios y evalúe cómo los cambios influyen en la valoración de PainReform Ltd. (PRFX), todo dentro de una sola plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | -100 | -25 | -25 | -25 | -25 | -25 |
EBITDA | -.7 | -1.7 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | -10295.35 | 100 | 60 | 60 | 60 | 60 | 60 |
Depreciation | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 17.44 | 100 | 83.49 | 83.49 | 83.49 | 83.49 | 83.49 |
EBIT | -.7 | -1.7 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | -10312.79 | 100 | 60 | 60 | 60 | 60 | 60 |
Total Cash | .9 | 15.7 | 16.5 | 4.1 | 8.0 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .1 | .2 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 63.95 | 100 | 92.79 | 92.79 | 92.79 | 92.79 | 92.79 |
Inventories | .0 | 2.0 | 2.2 | 7.8 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 9096.51 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | .0 | .7 | .1 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 243.02 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | -6.98 | 100 | -1.4 | -1.4 | -1.4 | -1.4 | -1.4 |
Tax Rate, % | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 | -0.0856898 |
EBITAT | -1.0 | -1.8 | -7.2 | -8.9 | -9.6 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1.0 | -3.1 | -8.2 | -14.2 | -1.7 | -.2 | .0 | .0 | .0 | .0 |
WACC, % | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 | 51.56 |
PV UFCF | ||||||||||
SUM PV UFCF | -.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | 0 | |||||||||
Net Debt | -8 | |||||||||
Equity Value | 8 | |||||||||
Diluted Shares Outstanding, MM | 0 | |||||||||
Equity Value Per Share | 35.86 |
What You Will Get
- Editable Forecast Inputs: Flexibly adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: PainReform Ltd.'s (PRFX) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life PRFX Financials: Pre-filled historical and projected data for PainReform Ltd.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate PainReform’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize PainReform’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered PainReform data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for PainReform’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose PainReform Ltd. (PRFX) Calculator?
- Precision: Utilizes accurate PainReform financial data for reliable results.
- Customizable: Allows users to adjust and test various inputs effortlessly.
- Efficiency: Avoid the complexity of creating a financial model from the ground up.
- Expert-Level: Crafted with the precision and usability expected by industry leaders.
- Intuitive: Simple to navigate, suitable for users with varying levels of financial expertise.
Who Should Use PainReform Ltd. (PRFX)?
- Healthcare Professionals: Understand the latest advancements in pain management therapies and their applications.
- Researchers: Utilize innovative models in your studies related to pain treatment methodologies.
- Investors: Evaluate your investment strategies by analyzing market trends and performance of PainReform Ltd. (PRFX).
- Pharmaceutical Analysts: Enhance your analysis with a comprehensive understanding of the pain management sector.
- Patients and Advocates: Gain insights into emerging treatments and their potential impact on pain relief.
What the Template Contains
- Preloaded PRFX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.